Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
January 24, 2018
NOHLA THERAPEUTICS GRANTED ORPHAN DRUG DESIGNATION IN THE EUROPEAN UNION FOR NLA101 IN THE TREATMENT OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
January 23, 2018
AUDENTES THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK
January 17, 2018
HOMOLOGY MEDICINES APPOINTS MATTHEW R. PATTERSON TO BOARD OF DIRECTORS
January 8, 2018
NOHLA THERAPEUTICS ANNOUNCES HIRING OF JIM JOHNSON AS CHIEF FINANCIAL OFFICER
January 4, 2018
NEUROGASTRX, INC. RAISES $45M SERIES A TO BRING LEAD GI CANDIDATE THROUGH PROOF OF CONCEPT, JIM O’MARA NAMED CHIEF EXECUTIVE OFFICER
January 4, 2018
ARVINAS ANNOUNCES RESEARCH COLLABORATION AND LICENSE AGREEMENT WITH PFIZER INC. FOR THE DISCOVERY AND DEVELOPMENT OF PROTEIN DEGRADATION DRUG CANDIDATES
January 4, 2018
EXPANSION THERAPEUTICS RAISES $55.3 MILLION IN SERIES A FINANCING TO ADVANCE PORTFOLIO OF NOVEL RNA TARGETED SMALL MOLECULE MEDICINES TO TREAT RARE DISEASES
January 3, 2018
EXPANSION THERAPEUTICS RAISES $55.3 MILLION IN SERIES A FINANCING TO ADVANCE PORTFOLIO OF NOVEL RNA TARGETED SMALL MOLECULE MEDICINES TO TREAT RARE DISEASES
January 2, 2018
PEAR THERAPEUTICS COMPLETES $50 MILLION SERIES B FINANCING
December 21, 2017
MILLENDO THERAPEUTICS ANNOUNCES ACQUISITION OF ALIZÉ PHARMA SAS TO EXPAND ORPHAN ENDOCRINOLOGY PIPELINE
« Previous Page
1
…
80
81
82
83
84
…
119
Next Page »